Benoxaprofen kinetics in renal impairment

Area of Science:

• Pharmacokinetics
• Nephrology
• Drug Metabolism

Background:

• Benoxaprofen is a non-steroidal anti-inflammatory drug (NSAID).
• Understanding drug kinetics in renal impairment is crucial for safe and effective therapeutic guidelines.
• Limited data exists on benoxaprofen's behavior in patients with compromised kidney function.

Purpose of the Study:

• To investigate the pharmacokinetic profile of benoxaprofen in adults with varying degrees of renal function.
• To determine the influence of renal impairment on benoxaprofen's absorption, distribution, metabolism, and excretion.
• To establish evidence-based therapeutic guidelines for benoxaprofen dosing in renal disease.

Main Methods:

• A single 600-mg dose of benoxaprofen was administered to 26 adult subjects.
• Subjects included individuals with normal and decreased renal function.
• Plasma concentrations, elimination half-life, and plasma clearance were measured.
• The effect of hemodialysis on benoxaprofen removal was assessed.

Main Results:

• Mean peak plasma concentrations of benoxaprofen were consistent across all renal function groups.
• Elimination half-life and plasma clearance showed a significant correlation with creatinine clearance.
• Hemodialysis was ineffective in removing benoxaprofen from the plasma.
• A dosage nomogram indicated a need for a 50% dose reduction in severe renal failure.

Conclusions:

• Benoxaprofen's peak plasma levels are not affected by renal function.
• Renal function significantly impacts benoxaprofen's elimination rate.
• A reduced maintenance dose is recommended for patients with severe renal impairment to prevent accumulation and potential toxicity.